Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1996
Cognitive effects of neonatal hippocampal lesions in a rat model of schizophreniaR A Chambers, J Moore, J P McEvoy, et al.
Psychopharmacology|May 1, 1995
Haloperidol increases smoking in patients with schizophreniaJ P McEvoy, O Freudenreich, E D Levin, et al.
Dialogues in Clinical Neuroscience|October 29, 2011
Comparative effectiveness of antipsychotic drugs in schizophreniaT S Stroup, J A Lieberman, M S Swartz, et al.
The American Journal of Psychiatry|November 1, 1993
Use of psychopathology vignettes by patients with schizophrenia or schizoaffective disorder and by mental health professionals to judge patients' insightJ P McEvoy, N R Schooler, E Friedman, et al.
Hospital & Community Psychiatry|December 1, 1981
Measuring chronic schizophrenic patients attitudes toward their illness and treatmentJ P McEvoy, J Aland, W H Wilson, et al.
International Pharmacopsychiatry|January 1, 1980
A double-blind comparison of three dosages of flutroline (CP-36,584) in the treatment of schizophreniaJ P McEvoy, S Berney, W H Wilson, et al.
Pharmacopsychiatria|May 1, 1982
Bromperidol maintenance in schizophreniaJ P McEvoy, W H Wilson, T A Ban, et al.
International Pharmacopsychiatry|January 1, 1980
Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical studyW M Petrie, J P McEvoy, W H Wilson, et al.
Schizophrenia Bulletin|January 1, 1996
Common sense, insight, and neuropsychological test performance in schizophrenia patientsJ P McEvoy, M Hartman, D Gottlieb, et al.
Psychopharmacology|January 1, 1993
An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patientsJ P McEvoy, G Movin-Osswald, G Uppfeldt, et al.
Pageof 6